5-amino-1mq preclinical studies Peptide Therapy 5-Amino-1MQ NNMT Inhibitor | Research

Rotate injection sites to prevent tissue damage and maintain optimal absorption

Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults

Under no circumstances should these peptides be used for any purpose other than research

But what I didnt disclose were some of the game-changing fat loss results that took place after 11 days of eating a high-fat diet while receiving 5-Amino 1MQ, or that the mice were obese due to eating a high-fat diet for 16 weeks prior to the experiment: Body weight went down by 6% The rate of lipogenesis (i.e